Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma.

Literature DB >> 25133021

Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma.

Yuichi Sanada¹, Yujo Kawashita¹, Satomi Okada¹, Takashi Azuma¹, Shigetoshi Matsuo¹.

Abstract

Intrahepatic cholangiocarcinoma is macroscopically classified into three subtypes, mass-forming-type, periductal infiltrating-type, and intraductal growth-type. Each subtype should be preoperatively differentiated to perform the valid surgical resection. Recent researches have revealed the clinical, radiologic, pathobiological characteristics of each subtype. We reviewed recently published studies covering various aspects of intrahepatic cholangiocarcinoma (ICC), focusing especially on the macroscopic subtypes and stem cell features to better understand the pathophysiology of ICC and to establish the valid therapeutic strategy.

Entities: Disease

Keywords: Combined hepatocellular-cholangiocarcinoma; Hepatic progenitor cells; Intrahepatic cholangiocarcinoma; Macroscopic subtype

Year: 2014 PMID： 25133021 PMCID： PMC4133518 DOI： 10.4291/wjgp.v5.i3.188

Source DB: PubMed Journal: World J Gastrointest Pathophysiol ISSN： 2150-5330

89 in total

1. Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Authors: Xian-Huan Yu; Lei-Bo Xu; Hong Zeng; Rui Zhang; Jie Wang; Chao Liu
Journal: Hepatobiliary Pancreat Dis Int Date: 2011-12

2. Clinicopathological significance of E-cadherin, β-catenin and epidermal growth factor receptor expression in intrahepatic cholangiocarcinoma.

Authors: Mi Jin Gu; Joon Hyuk Choi
Journal: Hepatogastroenterology Date: 2012-06

3. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.

Authors: Shun-Ichi Ariizumi; Yoshihito Kotera; Satoshi Katagiri; Masayuki Nakano; Masakazu Yamamoto
Journal: Ann Surg Oncol Date: 2011-11-24 Impact factor: 5.344

4. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.

Authors: Ya-yong Li; Hao Li; Pin Lv; Gang Liu; Xiao-rong Li; Bu-ning Tian; Dao-jin Chen
Journal: J Gastrointest Surg Date: 2011-01-19 Impact factor: 3.452

5. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.

Authors: Cédric Coulouarn; Catherine Cavard; Laura Rubbia-Brandt; Anne Audebourg; Florent Dumont; Sébastien Jacques; Pierre-Alexandre Just; Bruno Clément; Hélène Gilgenkrantz; Christine Perret; Benoît Terris
Journal: Carcinogenesis Date: 2012-06-13 Impact factor: 4.944

6. Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma.

Authors: Nichapavee Nutthasirikul; Temduang Limpaiboon; Chanvit Leelayuwat; Siriporn Patrakitkomjorn; Patcharee Jearanaikoon
Journal: Int J Oncol Date: 2013-02-08 Impact factor: 5.650

7. Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma.

Authors: Shinichi Aishima; Yohei Mano; Yuki Tanaka; Yuichiro Kubo; Ken Shirabe; Yoshihiko Maehara; Yoshinao Oda
Journal: Hum Pathol Date: 2012-12-20 Impact factor: 3.466

8. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.

Authors: Teijiro Hirashita; Yukio Iwashita; Masayuki Ohta; Yoko Komori; Hidetoshi Eguchi; Kazuhiro Yada; Seigo Kitano
Journal: J Gastrointest Surg Date: 2012-01-13 Impact factor: 3.452

9. Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma.

Authors: Xing Yao; Xiang Wang; Zishu Wang; Licheng Dai; Guolei Zhang; Qiang Yan; Weimin Zhou
Journal: Onco Targets Ther Date: 2012-10-12 Impact factor: 4.147

7. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.

Authors: Ze-Wu Meng; Wei Pan; Hai-Jie Hong; Jiang-Zhi Chen; Yan-Ling Chen
Journal: Medicine (Baltimore) Date: 2017-08 Impact factor: 1.889

7 in total

Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma.

1. Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma.

2. Clinicopathological significance of E-cadherin, β-catenin and epidermal growth factor receptor expression in intrahepatic cholangiocarcinoma.

3. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.

4. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.

5. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.

6. Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma.

7. Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma.

8. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.

9. Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma.

10. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.

Review 1. Pathology of intrahepatic cholangiocarcinoma.

2. MicroRNA-212 targets FOXA1 and suppresses the proliferation and invasion of intrahepatic cholangiocarcinoma cells.

3. Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.

4. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.

5. SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma.

6. Macroscopic types of intrahepatic cholangiocarcinoma and the eighth edition of AJCC/UICC TNM staging system.

7. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.